Episode Details
Back to EpisodesExploring GLP-1 Receptor Agonists for Neurodegeneration - Part 1
Published 10 months, 2 weeks ago
Description
In part one of this two-part series, Dr. Vikram Karnik and Dr. Lorraine Kalia discuss recent clinical trials on exenatide as a disease-modifying therapy for Parkinson disease.
Show reference:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00161-8/abstract